The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity
- PMID: 3036087
- PMCID: PMC1147660
- DOI: 10.1042/bj2420033
The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity
Abstract
The hormone-stimulated 'dense-vesicle' cyclic AMP phosphodiesterase was solubilized as a proteolytically 'clipped' species, and purified to apparent homogeneity from rat liver with a 2000-3000-fold purification and a 13-18% yield. It appeared to be a dimer (Mr 112,000), of two Mr-57,000 subunits. Solubilization of either a liver or a hepatocyte membrane fraction, with sodium cholate in the presence of the protein inhibitor benzamidine, identified three protein bands which could be immunoprecipitated by a polyclonal antibody raised against the pure enzyme. The major band at Mr 62,000 is suggested to be the native 'dense-vesicle' enzyme, having a Mr-5000 extension which serves to anchor this enzyme to the membrane and which is cleaved off during proteolytic solubilization; the Mr-200,000 band is an aggregate of the Mr-62,000 species, and the Mr-63,000 species is possibly a precursor. The purified 'clipped' enzyme hydrolysed cyclic AMP with kinetics indicative of apparent negative co-operativity, with a Hill coefficient (h) of 0.43 and limiting kinetic constants of Km1 = 0.3 +/- 0.05 microM, Km2 = 29 +/- 6 microM, Vmax.1 = 0.114 +/- 0.015 unit/mg of protein and Vmax.2 = 0.633 +/- 0.054 unit/mg of protein. It hydrolysed cyclic GMP with Michaelis kinetics, Km = 10 +/- 1 microM and Vmax. = 4.1 +/- 0.2 units/mg of protein. Cyclic GMP was a potent inhibitor of cyclic AMP hydrolysis, with an IC50 (concn. giving 50% inhibition) of 0.20 +/- 0.01 microM-cyclic GMP when assayed at 0.1 microM-cyclic AMP. This enzyme was inhibited potently by several drugs known to exert positive inotropic effects on the heart, was extremely thermolabile, with a half-life of 4.5 +/- 0.5 min at 40 degrees C, and was shown to be distinct from the rat liver insulin-stimulated peripheral-plasma-membrane cyclic AMP phosphodiesterase [Marchmont, Ayad & Houslay (1981) Biochem. J. 195, 645-652].
Similar articles
-
Identification and characterization of both the cytosolic and particulate forms of cyclic GMP-stimulated cyclic AMP phosphodiesterase from rat liver.Biochem J. 1986 Mar 1;234(2):325-34. doi: 10.1042/bj2340325. Biochem J. 1986. PMID: 3013156 Free PMC article.
-
Specific antibodies and the selective inhibitor ICI 118233 demonstrate that the hormonally stimulated 'dense-vesicle' and peripheral-plasma-membrane cyclic AMP phosphodiesterases display distinct tissue distributions in the rat.Biochem J. 1987 Dec 15;248(3):897-901. doi: 10.1042/bj2480897. Biochem J. 1987. PMID: 2829845 Free PMC article.
-
Purification and properties of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes.Biochem J. 1981 Jun 1;195(3):645-52. doi: 10.1042/bj1950645. Biochem J. 1981. PMID: 6274308 Free PMC article.
-
Insulin, glucagon and the receptor-mediated control of cyclic AMP concentrations in liver. Twenty-second Colworth medal lecture.Biochem Soc Trans. 1986 Apr;14(2):183-93. doi: 10.1042/bst0140183. Biochem Soc Trans. 1986. PMID: 3011541 Review. No abstract available.
-
Hormone sensitive phosphodiesterase of liver and adipose tissue.Int J Biochem. 1991;23(7-8):649-55. doi: 10.1016/0020-711x(91)90033-j. Int J Biochem. 1991. PMID: 1650718 Review. No abstract available.
Cited by
-
Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A.Blood. 2007 Sep 1;110(5):1475-82. doi: 10.1182/blood-2006-10-052522. Epub 2007 Mar 28. Blood. 2007. PMID: 17392505 Free PMC article. Clinical Trial.
-
Cyclic nucleotide phosphodiesterases in pancreatic islets.Diabetologia. 2003 Sep;46(9):1179-89. doi: 10.1007/s00125-003-1176-7. Epub 2003 Aug 7. Diabetologia. 2003. PMID: 12904862 Review.
-
Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases.J Clin Invest. 1995 Apr;95(4):1528-38. doi: 10.1172/JCI117825. J Clin Invest. 1995. PMID: 7706458 Free PMC article.
-
Activation and phosphorylation of the 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase by cyclic AMP-dependent protein kinase.Biochem J. 1989 May 15;260(1):27-36. doi: 10.1042/bj2600027. Biochem J. 1989. PMID: 2549954 Free PMC article.
-
Subcellular localization and hormone sensitivity of adipocyte cyclic AMP phosphodiesterase.Biochem J. 1989 Sep 15;262(3):867-72. doi: 10.1042/bj2620867. Biochem J. 1989. PMID: 2556112 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical